Back to search
High Risk Myeloid Malignancies
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk Myeloid Malignancies trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk Myeloid Malignancies trials you may qualify forThe purpose of this study is to compare the efficacy and safety of venetoclax combined with the CACAG regimen with the traditional "3+7" regimen in the treatmen…
The drug that will be investigated in the trial is an antibody, GEN3018. Since this is the first trial of GEN3018 in humans, the main purpose is to evaluate saf…
This phase I trial tests the safety, side effects, and best dose of ASTX727 and filgrastim for the treatment of children with high risk acute myeloid leukemia t…
This phase II MyeloMATCH treatment trial tests whether the standard approach of cytarabine and daunorubicin in comparison to the following experimental regimens…
This trial represents a single institution phase I/II pilot study with the primary objective of establishing the safety and feasibility of generating and infusi…
This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patient…
This study was designed as a prospective, multicenter, open-label, randomized controlled trial. Eligible participants were patients aged 15-65 years with high r…
A study of siremadlin in combination with venetoclax plus azacitidine in adult participants with AML who are ineligible for chemotherapy. The primary purpose o…